Amicogen, Inc. (092040.KQ)
KRW 3930.0
(-3.2%)
KRW 3930.0
(-3.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 467.09 Billion KRW | 8.72% |
| 2022 | 429.65 Billion KRW | 4.48% |
| 2021 | 411.22 Billion KRW | 45.12% |
| 2020 | 283.36 Billion KRW | 17.38% |
| 2019 | 241.4 Billion KRW | 4.41% |
| 2018 | 231.21 Billion KRW | 41.4% |
| 2017 | 163.51 Billion KRW | 11.74% |
| 2016 | 146.33 Billion KRW | -8.45% |
| 2015 | 159.84 Billion KRW | 194.01% |
| 2014 | 54.36 Billion KRW | 22.56% |
| 2013 | 44.36 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 489.77 Billion KRW | -0.0% |
| 2024 Q1 | 489.78 Billion KRW | 4.86% |
| 2023 Q4 | 467.09 Billion KRW | 1.23% |
| 2023 FY | 467.09 Billion KRW | 8.72% |
| 2023 Q1 | 462.2 Billion KRW | 7.58% |
| 2023 Q2 | 452.02 Billion KRW | -2.2% |
| 2023 Q3 | 461.4 Billion KRW | 2.08% |
| 2022 Q2 | 427.48 Billion KRW | -2.64% |
| 2022 Q3 | 486.69 Billion KRW | 13.85% |
| 2022 FY | 429.65 Billion KRW | 4.48% |
| 2022 Q1 | 439.07 Billion KRW | 6.77% |
| 2022 Q4 | 429.65 Billion KRW | -11.72% |
| 2021 Q2 | 413.78 Billion KRW | 42.2% |
| 2021 Q4 | 411.22 Billion KRW | -0.99% |
| 2021 Q3 | 415.34 Billion KRW | 0.38% |
| 2021 FY | 411.22 Billion KRW | 45.12% |
| 2021 Q1 | 290.99 Billion KRW | 2.69% |
| 2020 Q2 | 265.02 Billion KRW | 11.91% |
| 2020 Q3 | 269.54 Billion KRW | 1.71% |
| 2020 FY | 283.36 Billion KRW | 17.38% |
| 2020 Q1 | 236.81 Billion KRW | -1.9% |
| 2020 Q4 | 283.36 Billion KRW | 5.13% |
| 2019 Q3 | 230.11 Billion KRW | -3.93% |
| 2019 Q2 | 239.52 Billion KRW | -11.68% |
| 2019 Q1 | 271.21 Billion KRW | 17.3% |
| 2019 FY | 241.4 Billion KRW | 4.41% |
| 2019 Q4 | 241.4 Billion KRW | 4.9% |
| 2018 Q4 | 231.21 Billion KRW | 16.69% |
| 2018 Q2 | 207.44 Billion KRW | 18.52% |
| 2018 Q1 | 175.03 Billion KRW | 7.04% |
| 2018 FY | 231.21 Billion KRW | 41.4% |
| 2018 Q3 | 198.14 Billion KRW | -4.49% |
| 2017 Q3 | 161.09 Billion KRW | 5.74% |
| 2017 Q4 | 163.51 Billion KRW | 1.5% |
| 2017 FY | 163.51 Billion KRW | 11.74% |
| 2017 Q1 | 144.89 Billion KRW | -0.98% |
| 2017 Q2 | 152.34 Billion KRW | 5.15% |
| 2016 Q1 | 145.49 Billion KRW | -8.98% |
| 2016 FY | 146.33 Billion KRW | -8.45% |
| 2016 Q4 | 146.33 Billion KRW | 5.52% |
| 2016 Q3 | 138.67 Billion KRW | -4.21% |
| 2016 Q2 | 144.77 Billion KRW | -0.49% |
| 2015 Q3 | 174.07 Billion KRW | 224.69% |
| 2015 Q2 | 53.61 Billion KRW | -0.87% |
| 2015 Q1 | 54.08 Billion KRW | -0.52% |
| 2015 FY | 159.84 Billion KRW | 194.01% |
| 2015 Q4 | 159.84 Billion KRW | -8.18% |
| 2014 FY | 54.36 Billion KRW | 22.56% |
| 2014 Q4 | 54.36 Billion KRW | 8.6% |
| 2014 Q2 | 47.54 Billion KRW | 3.33% |
| 2014 Q1 | 46.01 Billion KRW | 3.72% |
| 2014 Q3 | 50.06 Billion KRW | 5.3% |
| 2013 FY | 44.36 Billion KRW | 0.0% |
| 2013 Q3 | 43.97 Billion KRW | 0.0% |
| 2013 Q4 | 44.36 Billion KRW | 0.88% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Co., Ltd. | 751.72 Billion KRW | 37.863% |
| iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -373.66% |
| BINEX Co., Ltd. | 257.01 Billion KRW | -81.742% |
| Bioneer Corporation | 315.48 Billion KRW | -48.056% |
| Anterogen.Co.,Ltd. | 149.43 Billion KRW | -212.583% |
| MEDIPOST Co., Ltd. | 449.39 Billion KRW | -3.94% |
| CrystalGenomics, Inc. | 243.11 Billion USD | -92.13% |
| Helixmith Co., Ltd | 227.27 Billion KRW | -105.517% |
| Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 72.931% |
| Medy-Tox Inc. | 611.62 Billion KRW | 23.63% |
| Peptron, Inc. | 52.49 Billion KRW | -789.779% |
| Genexine, Inc. | 376.58 Billion KRW | -24.035% |
| HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | -132.624% |
| LegoChem Biosciences, Inc. | 189.5 Billion KRW | -146.487% |
| ALTEOGEN Inc. | 256.09 Billion KRW | -82.389% |
| PharmaResearch Co., Ltd. | 535.28 Billion KRW | 12.738% |
| SillaJen, Inc. | 76.71 Billion KRW | -508.875% |
| JETEMA, Co., Ltd. | 252.14 Billion KRW | -85.248% |
| OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -354.265% |
| Genomictree Inc. | 132.84 Billion KRW | -251.614% |
| MedPacto, Inc. | 80.47 Billion KRW | -480.431% |
| D&D Pharmatech | 79.2 Billion KRW | -489.743% |
| EASY BIO,Inc. | 172.04 Billion KRW | -171.503% |
| GI Innovation, Inc. | 81.34 Billion KRW | -474.252% |